The Department of Justice and State Attorney Generals are pursuing high-profile criminal antitrust matters in the healthcare industry. Understanding the rules of the road and enforcement priorities in healthcare is more important than ever as the COVID-19 crisis heightens scrutiny of business practices among providers, insurers, medical-device manufacturers, and pharmaceutical companies.
This program will explore:
- the history of criminal antitrust enforcement in healthcare
- conduct that is targeted for criminal prosecution
- recent DOJ and state healthcare antitrust matters
- best practices for preventing problematic behavior
This program is sponsored by the Health Care & Pharmaceuticals committee.